CENOBAMATE

CENOBAMATE was reported 8531 times

CENOBAMATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPILEPSY SURGERY 6 0.2400
1 BILATERAL TONIC CLONIC SEIZURE 2 0.1538
2 OPSOCLONUS 3 0.1304
3 ICTAL BRADYCARDIA SYNDROME 2 0.1250
4 POLYNEUROPATHY IDIOPATHIC PROGRESSIVE 7 0.1045
5 EYELID MYOKYMIA 3 0.0968
6 CORPUS CALLOSOTOMY 3 0.0938
7 PNEUMONITIS ASPIRATION 32 0.0936
8 VAGAL NERVE STIMULATOR IMPLANTATION 25 0.0817
9 SEIZURE CLUSTER 64 0.0772
10 PRODUCT REGIMEN CONFUSION 4 0.0769
11 GELASTIC SEIZURE 2 0.0690
12 AURA 117 0.0627
13 ELECTROENCEPHALOGRAM 3 0.0536
14 MATERNAL USE OF ILLICIT DRUGS 2 0.0526
15 POSTICTAL PSYCHOSIS 8 0.0513
16 BRAIN LOBECTOMY 3 0.0508
17 CORTICAL DYSPLASIA 3 0.0508
18 DRUG TITRATION ERROR 100 0.0387
19 INCREASED NEED FOR SLEEP 9 0.0386
20 NEUROPROSTHESIS IMPLANTATION 5 0.0360
21 DRUG METABOLITE LEVEL HIGH 3 0.0357
22 FOCAL DYSCOGNITIVE SEIZURES 38 0.0334
23 DEJA VU 9 0.0327
24 ATONIC SEIZURES 27 0.0314
25 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 16 0.0299
26 CHANGE IN SEIZURE PRESENTATION 19 0.0294
27 CANNABINOID HYPEREMESIS SYNDROME 2 0.0290
28 PARTIAL SEIZURES 131 0.0250
29 MITRAL VALVE THICKENING 7 0.0235
30 MULTIPLE-DRUG RESISTANCE 72 0.0232
31 PETIT MAL EPILEPSY 116 0.0227
32 MEDICAL DEVICE BATTERY REPLACEMENT 3 0.0222
33 SEIZURE 2543 0.0220
34 DRUG TITRATION ISSUE 4 0.0219
35 TONIC CONVULSION 30 0.0212
36 BENZODIAZEPINE DRUG LEVEL INCREASED 2 0.0211
37 ELECTROCARDIOGRAM QT SHORTENED 6 0.0198
38 DRUG TITRATION 3 0.0192
39 BRAIN OPERATION 40 0.0175
40 POSTICTAL PARALYSIS 4 0.0165
41 INCREASED DOSE ADMINISTERED 5 0.0160
42 HYPERVITAMINOSIS 2 0.0145
43 GENERALISED TONIC-CLONIC SEIZURE 221 0.0133
44 HISTRIONIC PERSONALITY DISORDER 2 0.0132
45 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 4 0.0129
46 PSYCHOGENIC SEIZURE 12 0.0128
47 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 6 0.0128
48 MYOCLONIC EPILEPSY 19 0.0125
49 VESTIBULAR MIGRAINE 3 0.0124
50 AORTIC VALVE THICKENING 2 0.0124
51 EPILEPTIC AURA 3 0.0116
52 PRODUCT PACKAGING DIFFICULT TO OPEN 29 0.0111
53 EXAGGERATED STARTLE RESPONSE 2 0.0110
54 POSTICTAL STATE 11 0.0106
55 SLOW SPEECH 25 0.0103
56 CRANIOTOMY 4 0.0098
57 DUPLICATE THERAPY ERROR 3 0.0093
58 SKULL FRACTURE 15 0.0092
59 SELF-DESTRUCTIVE BEHAVIOUR 8 0.0092
60 COLON CANCER STAGE II 2 0.0090
61 GASTROSTOMY 14 0.0090
62 REPETITIVE SPEECH 5 0.0089
63 OCCIPITAL NEURALGIA 5 0.0088
64 HEAD BANGING 5 0.0088
65 THROMBOCYTOSIS 32 0.0087
66 SIMPLE PARTIAL SEIZURES 7 0.0087
67 FEELING DRUNK 61 0.0082
68 CLONIC CONVULSION 6 0.0082
69 PATIENT ELOPEMENT 3 0.0082
70 BEHAVIOUR DISORDER 44 0.0081
71 RAPID EYE MOVEMENTS SLEEP ABNORMAL 3 0.0071
72 TEMPORAL LOBE EPILEPSY 3 0.0069
73 PARADOXICAL DRUG REACTION 25 0.0068
74 STARING 16 0.0066
75 ATAXIA 78 0.0066
76 TRACHEITIS 5 0.0066
77 COMA SCALE ABNORMAL 19 0.0066
78 DRUG DOSE TITRATION NOT PERFORMED 12 0.0065
79 DIPLOPIA 167 0.0064
80 PRODUCT DOSE OMISSION ISSUE 1880 0.0064
81 PULMONARY VALVE INCOMPETENCE 9 0.0062
82 HYPERMAGNESAEMIA 4 0.0061
83 IDIOSYNCRATIC DRUG REACTION 6 0.0061
84 HYPERSOMNIA 174 0.0061
85 STATUS EPILEPTICUS 68 0.0060
86 LOSS OF EMPLOYMENT 18 0.0060
87 FEBRILE CONVULSION 7 0.0057
88 CIRCUMORAL OEDEMA 2 0.0057
89 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
90 SLEEP DEFICIT 12 0.0057
91 GASTROINTESTINAL TUBE INSERTION 14 0.0056
92 ANTICONVULSANT DRUG LEVEL INCREASED 9 0.0056
93 PERIPHERAL SENSORIMOTOR NEUROPATHY 7 0.0056
94 FEEDING TUBE USER 2 0.0055
95 MACROGLOSSIA 3 0.0055
96 ELECTROENCEPHALOGRAM ABNORMAL 17 0.0054
97 OEDEMATOUS PANCREATITIS 3 0.0053
98 LIP INJURY 7 0.0053
99 ADENOIDECTOMY 2 0.0052
100 CONVULSIVE THRESHOLD LOWERED 2 0.0051
101 DROPPED HEAD SYNDROME 2 0.0051
102 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
103 PRETERM PREMATURE RUPTURE OF MEMBRANES 6 0.0050
104 METAMORPHOPSIA 9 0.0049
105 TONGUE BITING 10 0.0048
106 PSYCHOMOTOR SKILLS IMPAIRED 12 0.0046
107 CEREBELLAR SYNDROME 10 0.0046
108 DYSPHEMIA 20 0.0046
109 FEAR OF DEATH 10 0.0044
110 CLUMSINESS 12 0.0044
111 SHOULDER FRACTURE 7 0.0043
112 LIVING IN RESIDENTIAL INSTITUTION 8 0.0043
113 ANTICONVULSANT DRUG LEVEL DECREASED 6 0.0042
114 INTRUSIVE THOUGHTS 5 0.0042
115 LACRIMATION DECREASED 2 0.0042
116 FACE INJURY 16 0.0042
117 LABILE BLOOD PRESSURE 5 0.0042
118 BITE 3 0.0041
119 NYSTAGMUS 22 0.0041
120 SOMNOLENCE 823 0.0041
121 SEDATION 107 0.0041
122 EXCESSIVE EYE BLINKING 6 0.0041
123 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 2 0.0040
124 MOUTH INJURY 6 0.0040
125 INTELLECTUAL DISABILITY 6 0.0039
126 EYE CONTUSION 8 0.0038
127 INTERCEPTED PRODUCT PRESCRIBING ERROR 5 0.0038
128 BRAIN FOG 59 0.0038
129 DROOLING 26 0.0038
130 AORTIC VALVE INCOMPETENCE 16 0.0038
131 WRONG DOSE 9 0.0037
132 LEFT ATRIAL ENLARGEMENT 2 0.0037
133 SOMATIC SYMPTOM DISORDER 4 0.0037
134 COMMUNICATION DISORDER 14 0.0037
135 ECHOCARDIOGRAM ABNORMAL 5 0.0036
136 DYSARTHRIA 134 0.0036
137 CEREBRAL VENOUS SINUS THROMBOSIS 3 0.0036
138 MOANING 4 0.0035
139 LAZINESS 6 0.0035
140 READING DISORDER 8 0.0035
141 APATHY 51 0.0035
142 LABELLED DRUG-DRUG INTERACTION ISSUE 5 0.0035
143 INTESTINAL PSEUDO-OBSTRUCTION 3 0.0034
144 DROP ATTACKS 2 0.0034
145 PRODUCT PRESCRIBING ERROR 80 0.0034
146 DEEP BRAIN STIMULATION 2 0.0033
147 TRICUSPID VALVE INCOMPETENCE 26 0.0033
148 PRODUCT USE ISSUE 608 0.0032
149 PERSONALITY CHANGE 30 0.0032
150 HYPERAMMONAEMIA 16 0.0032
151 WRONG SCHEDULE 3 0.0031
152 EPILEPSY 96 0.0031
153 ANTICHOLINERGIC SYNDROME 5 0.0031
154 HYPERVIGILANCE 3 0.0031
155 SLOW RESPONSE TO STIMULI 4 0.0031
156 PRODUCT AVAILABILITY ISSUE 70 0.0031
157 BALANCE DISORDER 263 0.0030
158 HYPOVITAMINOSIS 4 0.0030
159 HEAD INJURY 94 0.0030
160 PSYCHOTIC BEHAVIOUR 3 0.0030
161 EYE MOVEMENT DISORDER 20 0.0029
162 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
163 INTENTIONAL UNDERDOSE 21 0.0029
164 ENDOTRACHEAL INTUBATION 8 0.0029
165 COORDINATION ABNORMAL 39 0.0028
166 BINGE EATING 3 0.0028
167 LANGUAGE DISORDER 6 0.0028
168 AMMONIA INCREASED 14 0.0027
169 AORTIC VALVE SCLEROSIS 2 0.0027
170 BLUNTED AFFECT 2 0.0027
171 AMPHETAMINES POSITIVE 2 0.0027
172 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0027
173 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 89 0.0026
174 FOLATE DEFICIENCY 3 0.0026
175 APHASIA 78 0.0026
176 HICCUPS 21 0.0026
177 HYPORESPONSIVE TO STIMULI 3 0.0026
178 HEAT EXHAUSTION 2 0.0025
179 BRADYPHRENIA 16 0.0024
180 ALTERED VISUAL DEPTH PERCEPTION 2 0.0024
181 AFFECTIVE DISORDER 19 0.0024
182 CAMPYLOBACTER INFECTION 2 0.0024
183 EDUCATIONAL PROBLEM 4 0.0024
184 ENCEPHALOPATHY 59 0.0024
185 WALKING DISABILITY 5 0.0024
186 CRANIOFACIAL FRACTURE 2 0.0023
187 GENITAL BURNING SENSATION 2 0.0023
188 TONIC CLONIC MOVEMENTS 3 0.0023
189 SPINAL CORD INJURY 4 0.0023
190 DRUG INTERACTION 364 0.0023
191 MOOD ALTERED 62 0.0023
192 DRUG LEVEL FLUCTUATING 2 0.0023
193 DRUG WITHDRAWAL CONVULSIONS 4 0.0022
194 HEAD TITUBATION 3 0.0022
195 POSTURE ABNORMAL 7 0.0021
196 IMPATIENCE 4 0.0021
197 ANGER 70 0.0021
198 REHABILITATION THERAPY 8 0.0021
199 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0020
200 STRABISMUS 6 0.0020
201 DRUG LEVEL INCREASED 33 0.0020
202 DYSSTASIA 58 0.0020
203 CRANIOCEREBRAL INJURY 6 0.0020
204 DROWNING 2 0.0020
205 WALKING AID USER 13 0.0020
206 INTENTIONAL DOSE OMISSION 56 0.0020
207 SEDATION COMPLICATION 5 0.0020
208 DAYDREAMING 3 0.0019
209 IMPULSE-CONTROL DISORDER 4 0.0019
210 PHYSICAL DECONDITIONING 5 0.0019
211 CONCUSSION 15 0.0019
212 ALTERED STATE OF CONSCIOUSNESS 41 0.0019
213 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 382 0.0019
214 MEMORY IMPAIRMENT 257 0.0019
215 ABNORMAL BEHAVIOUR 74 0.0019
216 OCULOGYRIC CRISIS 4 0.0019
217 LETHARGY 107 0.0019
218 MITRAL VALVE INCOMPETENCE 21 0.0019
219 THERAPY INTERRUPTED 132 0.0018
220 PULMONARY ARTERIAL PRESSURE INCREASED 3 0.0018
221 THERAPY CHANGE 18 0.0018
222 EOSINOPHILIA 32 0.0018
223 DYSGRAPHIA 12 0.0018
224 AORTIC DILATATION 2 0.0018
225 GAIT INABILITY 60 0.0018
226 PSYCHOMOTOR RETARDATION 5 0.0018
227 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
228 SLEEP TALKING 3 0.0018
229 SEIZURE LIKE PHENOMENA 3 0.0018
230 DEAFNESS BILATERAL 3 0.0018
231 METABOLIC SURGERY 2 0.0018
232 PRIAPISM 6 0.0017
233 TONGUE COATED 3 0.0017
234 DYSLEXIA 2 0.0017
235 ENURESIS 7 0.0017
236 NECK INJURY 5 0.0017
237 BRADYKINESIA 10 0.0017
238 DISTURBANCE IN ATTENTION 91 0.0017
239 IMPAIRED DRIVING ABILITY 19 0.0017
240 SELF-INJURIOUS IDEATION 7 0.0017
241 HEPATIC STEATOSIS 31 0.0017
242 AGGRESSION 83 0.0017
243 EMERGENCY CARE 5 0.0016
244 COGNITIVE DISORDER 77 0.0016
245 PSYCHIATRIC SYMPTOM 12 0.0016
246 DRUG INTOLERANCE 156 0.0016
247 TUNNEL VISION 3 0.0016
248 IMPULSIVE BEHAVIOUR 6 0.0016
249 NARCOLEPSY 3 0.0016
250 URINARY TRACT INFECTION BACTERIAL 4 0.0016
251 MECHANICAL VENTILATION 3 0.0016
252 HOSTILITY 4 0.0016
253 DRUG LEVEL DECREASED 16 0.0016
254 MICROCEPHALY 2 0.0016
255 STUPOR 5 0.0016
256 APGAR SCORE LOW 2 0.0016
257 HAND FRACTURE 11 0.0016
258 INCOHERENT 10 0.0015
259 IMPAIRED WORK ABILITY 33 0.0015
260 PERSONALITY DISORDER 4 0.0015
261 SPEECH DISORDER 80 0.0015
262 PRODUCT PREPARATION ISSUE 10 0.0015
263 PNEUMONIA ASPIRATION 38 0.0015
264 GAIT DISTURBANCE 289 0.0015
265 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
266 AGITATION 110 0.0015
267 OVERWEIGHT 8 0.0015
268 MUSCLE CONTRACTURE 3 0.0015
269 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
270 CARBON DIOXIDE INCREASED 2 0.0015
271 HYPOKINESIA 21 0.0014
272 DEPRESSION SUICIDAL 5 0.0014
273 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
274 DRUG TOLERANCE DECREASED 4 0.0014
275 SCREAMING 9 0.0014
276 FALL 470 0.0014
277 FEBRILE BONE MARROW APLASIA 6 0.0014
278 MENTAL IMPAIRMENT 34 0.0014
279 ERECTILE DYSFUNCTION 36 0.0014
280 HYPERPROLACTINAEMIA 9 0.0014
281 HOSPITALISATION 213 0.0014
282 SKIN LACERATION 15 0.0014
283 SLUGGISHNESS 14 0.0014
284 NEGATIVE THOUGHTS 4 0.0014
285 COLONOSCOPY 3 0.0014
286 DECREASED INTEREST 8 0.0014
287 SUICIDAL IDEATION 124 0.0014
288 HEART VALVE REPLACEMENT 2 0.0014
289 AMNESIA 88 0.0014
290 APRAXIA 2 0.0013
291 KNEE DEFORMITY 2 0.0013
292 IRRITABILITY 81 0.0013
293 MUSCLE TWITCHING 31 0.0013
294 MYOCLONUS 16 0.0013
295 DIZZINESS 668 0.0013
296 MYDRIASIS 17 0.0013
297 EYELID DISORDER 3 0.0013
298 FLAT AFFECT 3 0.0013
299 THINKING ABNORMAL 24 0.0013
300 PRODUCT SUPPLY ISSUE 9 0.0013
301 FEELING ABNORMAL 302 0.0013
302 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60 0.0012
303 THERAPY CESSATION 64 0.0012
304 LEARNING DISORDER 3 0.0012
305 EMOTIONAL DISORDER 38 0.0012
306 COSTOCHONDRITIS 2 0.0012
307 ACUTE PSYCHOSIS 3 0.0012
308 CRYING 44 0.0012
309 SMALL FOR DATES BABY 6 0.0012
310 VISION BLURRED 165 0.0012
311 VENTRICULAR HYPERTROPHY 3 0.0012
312 MOOD SWINGS 38 0.0012
313 SLEEP TERROR 5 0.0012
314 PRODUCT DISTRIBUTION ISSUE 11 0.0012
315 SWOLLEN TONGUE 37 0.0012
316 MOTOR DYSFUNCTION 12 0.0012
317 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
318 ABORTION INDUCED 11 0.0012
319 MILIARIA 2 0.0012
320 PARANOIA 20 0.0012
321 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
322 TOOTH INJURY 5 0.0012
323 ADVERSE EVENT 106 0.0011
324 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
325 BURNS SECOND DEGREE 2 0.0011
326 FANCONI SYNDROME ACQUIRED 2 0.0011
327 CARDIAC ABLATION 2 0.0011
328 VERTIGO 68 0.0011
329 HOSPICE CARE 11 0.0011
330 IMPAIRED QUALITY OF LIFE 16 0.0011
331 BLEPHAROSPASM 7 0.0011
332 FACIAL BONES FRACTURE 4 0.0011
333 CEREBRAL VENOUS THROMBOSIS 2 0.0011
334 ASPIRATION 12 0.0011
335 HYPERSEXUALITY 2 0.0011
336 MANIA 18 0.0011
337 HYPOMENORRHOEA 3 0.0011
338 HOMICIDE 2 0.0011
339 FATIGUE 845 0.0011
340 PRESCRIBED OVERDOSE 21 0.0011
341 DENTAL CARE 2 0.0011
342 EATING DISORDER 23 0.0011
343 HEAD DISCOMFORT 19 0.0011
344 INITIAL INSOMNIA 11 0.0011
345 SOMNAMBULISM 7 0.0011
346 REBOUND EFFECT 12 0.0011
347 ADVERSE DRUG REACTION 95 0.0011
348 APPETITE DISORDER 7 0.0011
349 LIP DISORDER 2 0.0011
350 CLAVICLE FRACTURE 4 0.0010
351 FIBULA FRACTURE 3 0.0010
352 LOSS OF CONSCIOUSNESS 131 0.0010
353 PRODUCT COMMUNICATION ISSUE 9 0.0010
354 STRIDOR 3 0.0010
355 TREMOR 168 0.0010
356 POLYDIPSIA 4 0.0010
357 HEPATIC ENZYME ABNORMAL 5 0.0010
358 METABOLIC ENCEPHALOPATHY 3 0.0010
359 MIXED LIVER INJURY 3 0.0010
360 EAR HAEMORRHAGE 2 0.0010
361 EYE INJURY 3 0.0010
362 THERMAL BURN 7 0.0010
363 DIASTOLIC DYSFUNCTION 3 0.0010
364 DILATATION VENTRICULAR 2 0.0010
365 HEPATIC PAIN 4 0.0009
366 CD4 LYMPHOCYTES DECREASED 2 0.0009
367 DISORIENTATION 37 0.0009
368 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
369 BRUXISM 5 0.0009
370 SUICIDE ATTEMPT 56 0.0009
371 CONFUSIONAL STATE 149 0.0009
372 NORMAL NEWBORN 5 0.0009
373 BACK INJURY 10 0.0009
374 NERVOUSNESS 48 0.0009
375 PRODUCT PRESCRIBING ISSUE 20 0.0009
376 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
377 TOXIC SKIN ERUPTION 9 0.0009
378 PRODUCT PHYSICAL ISSUE 18 0.0009
379 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
380 DYSKINESIA 36 0.0009
381 HALLUCINATION, AUDITORY 14 0.0009
382 EUPHORIC MOOD 9 0.0009
383 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
384 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
385 HYPONATRAEMIA 49 0.0009
386 MYASTHENIA GRAVIS 7 0.0009
387 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
388 HEPATIC FUNCTION ABNORMAL 32 0.0009
389 HANGOVER 3 0.0009
390 TIBIA FRACTURE 4 0.0009
391 LOGORRHOEA 3 0.0009
392 SKIN ABRASION 4 0.0008
393 DECREASED APPETITE 195 0.0008
394 THIRST 15 0.0008
395 QUALITY OF LIFE DECREASED 11 0.0008
396 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
397 INTENTIONAL OVERDOSE 52 0.0008
398 HYPOTONIA 8 0.0008
399 GROIN PAIN 7 0.0008
400 BLOOD SODIUM DECREASED 15 0.0008
401 PANIC ATTACK 29 0.0008
402 SNORING 3 0.0008
403 LOSS OF CONTROL OF LEGS 3 0.0008
404 PHOTOPSIA 5 0.0008
405 OFF LABEL USE 691 0.0008
406 FEAR 21 0.0008
407 PELVIC FRACTURE 6 0.0008
408 PERIORBITAL OEDEMA 4 0.0008
409 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
410 MALABSORPTION 4 0.0008
411 ROAD TRAFFIC ACCIDENT 32 0.0008
412 VENOUS THROMBOSIS 3 0.0008
413 HEPATOTOXICITY 17 0.0008
414 MATERNAL EXPOSURE DURING PREGNANCY 68 0.0008
415 INSOMNIA 203 0.0008
416 ABNORMAL DREAMS 21 0.0008
417 INCORRECT DOSE ADMINISTERED 173 0.0008
418 SARS-COV-2 TEST POSITIVE 10 0.0008
419 COMA 36 0.0008
420 CEREBRAL ATROPHY 3 0.0008
421 ANIMAL BITE 2 0.0007
422 ALCOHOL ABUSE 2 0.0007
423 DRUG RESISTANCE 19 0.0007
424 FEEDING DISORDER 15 0.0007
425 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
426 DEPRESSION 167 0.0007
427 TIC 4 0.0007
428 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
429 AUTISM SPECTRUM DISORDER 4 0.0007
430 NIGHTMARE 25 0.0007
431 DIZZINESS POSTURAL 7 0.0007
432 SUICIDAL BEHAVIOUR 3 0.0007
433 DEPRESSED MOOD 38 0.0007
434 ELECTRIC SHOCK SENSATION 2 0.0007
435 HALLUCINATIONS, MIXED 3 0.0007
436 ANKLE FRACTURE 11 0.0007
437 INABILITY TO AFFORD MEDICATION 7 0.0007
438 CARDIAC VALVE DISEASE 4 0.0007
439 NEPHROLITHIASIS 32 0.0007
440 LIP PAIN 2 0.0007
441 HEPATIC LESION 3 0.0007
442 EYELID MARGIN CRUSTING 2 0.0007
443 WITHDRAWAL SYNDROME 29 0.0007
444 ILLNESS 71 0.0007
445 DRY THROAT 7 0.0007
446 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
447 GRIP STRENGTH DECREASED 6 0.0007
448 CEREBRAL DISORDER 5 0.0007
449 WHEELCHAIR USER 3 0.0007
450 CHOKING 13 0.0007
451 SCRATCH 7 0.0007
452 PAROSMIA 5 0.0007
453 INCONTINENCE 7 0.0007
454 MIGRAINE 63 0.0007
455 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
456 TENSION 4 0.0007
457 HEMIPARESIS 11 0.0006
458 ABORTION SPONTANEOUS 26 0.0006
459 DECREASED ACTIVITY 7 0.0006
460 BRAIN DEATH 2 0.0006
461 DEMENTIA 18 0.0006
462 DELUSION 10 0.0006
463 PSYCHOTIC DISORDER 19 0.0006
464 PERFORMANCE STATUS DECREASED 3 0.0006
465 APNOEA 5 0.0006
466 URINARY INCONTINENCE 19 0.0006
467 INVESTIGATION 2 0.0006
468 SLEEP DISORDER 45 0.0006
469 VISUAL IMPAIRMENT 79 0.0006
470 BODY TEMPERATURE INCREASED 13 0.0006
471 PRODUCT PACKAGING ISSUE 6 0.0006
472 SUBDURAL HAEMATOMA 9 0.0006
473 LIMB INJURY 17 0.0006
474 HEADACHE 391 0.0006
475 OCULAR DISCOMFORT 7 0.0006
476 STILLBIRTH 3 0.0006
477 CHROMATURIA 14 0.0006
478 FRUSTRATION TOLERANCE DECREASED 5 0.0006
479 HEPATITIS ACUTE 4 0.0006
480 HYPOGAMMAGLOBULINAEMIA 4 0.0006
481 BEDRIDDEN 8 0.0006
482 LIVER FUNCTION TEST INCREASED 13 0.0006
483 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
484 POOR QUALITY SLEEP 13 0.0006
485 ADVERSE REACTION 8 0.0006
486 EXPIRED PRODUCT ADMINISTERED 20 0.0006
487 ACCIDENTAL OVERDOSE 22 0.0006
488 RESTLESSNESS 22 0.0006
489 ANXIETY DISORDER 2 0.0006
490 PRODUCT DISPENSING ERROR 13 0.0006
491 ANXIETY 169 0.0006
492 TOXICITY TO VARIOUS AGENTS 100 0.0006
493 DRUG TOLERANCE 3 0.0006
494 DYSPHAGIA 56 0.0006
495 IMPAIRED GASTRIC EMPTYING 8 0.0006
496 WRIST FRACTURE 7 0.0006
497 CERVICAL VERTEBRAL FRACTURE 2 0.0006
498 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
499 CATATONIA 3 0.0006
500 DEPRESSIVE SYMPTOM 2 0.0006
501 APPENDICECTOMY 2 0.0006
502 PANIC REACTION 4 0.0006
503 UPPER LIMB FRACTURE 11 0.0006
504 LIMB DISCOMFORT 17 0.0005
505 INTENTIONAL PRODUCT USE ISSUE 48 0.0005
506 OVERDOSE 118 0.0005
507 ASTHENOPIA 3 0.0005
508 INTENTIONAL SELF-INJURY 11 0.0005
509 WEIGHT DECREASED 152 0.0005
510 BRAIN NEOPLASM 5 0.0005
511 CHOKING SENSATION 3 0.0005
512 DRUG-INDUCED LIVER INJURY 17 0.0005
513 HYPERACUSIS 2 0.0005
514 LYMPHADENOPATHY 19 0.0005
515 RIB FRACTURE 11 0.0005
516 HIP FRACTURE 17 0.0005
517 MENTAL DISORDER 23 0.0005
518 PERONEAL NERVE PALSY 3 0.0005
519 NEUROLOGICAL SYMPTOM 3 0.0005
520 SLEEP APNOEA SYNDROME 10 0.0005
521 INCREASED APPETITE 10 0.0005
522 UNDERDOSE 38 0.0005
523 GYNAECOMASTIA 16 0.0005
524 METABOLIC DISORDER 3 0.0005
525 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
526 RASH 223 0.0005
527 LIGAMENT SPRAIN 5 0.0005
528 SEASONAL ALLERGY 7 0.0005
529 LACTIC ACIDOSIS 16 0.0005
530 TASTE DISORDER 10 0.0005
531 RESPIRATORY DEPRESSION 6 0.0005
532 ASTHENIA 184 0.0005
533 HEART RATE IRREGULAR 11 0.0005
534 MIDDLE INSOMNIA 9 0.0005
535 SECRETION DISCHARGE 6 0.0005
536 CONTUSION 46 0.0005
537 SWELLING OF EYELID 3 0.0005
538 ILL-DEFINED DISORDER 29 0.0005
539 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
540 BRADYCARDIA 25 0.0005
541 FACIAL PARALYSIS 4 0.0005
542 RETCHING 10 0.0005
543 JOINT INJURY 10 0.0005
544 MENTAL STATUS CHANGES 13 0.0005
545 ALCOHOLISM 2 0.0005
546 UNRESPONSIVE TO STIMULI 12 0.0005
547 MUSCLE STRAIN 4 0.0005
548 HORDEOLUM 2 0.0005
549 SURGERY 27 0.0005
550 IMMOBILE 2 0.0005
551 CORONAVIRUS INFECTION 3 0.0005
552 GINGIVAL SWELLING 2 0.0005
553 SPINAL FRACTURE 9 0.0004
554 ILEUS PARALYTIC 2 0.0004
555 LOSS OF LIBIDO 4 0.0004
556 ANAL INCONTINENCE 4 0.0004
557 PRODUCT USE COMPLAINT 7 0.0004
558 GASTROENTERITIS VIRAL 8 0.0004
559 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
560 CONSTIPATION 96 0.0004
561 VOMITING 206 0.0004
562 DISEASE COMPLICATION 2 0.0004
563 RESPIRATION ABNORMAL 3 0.0004
564 EYE OPERATION 2 0.0004
565 LYMPHOEDEMA 3 0.0004
566 MUSCLE TIGHTNESS 7 0.0004
567 PREMATURE BABY 13 0.0004
568 MUSCULAR WEAKNESS 49 0.0004
569 HUNGER 6 0.0004
570 FEELING OF DESPAIR 2 0.0004
571 HALLUCINATION, VISUAL 9 0.0004
572 HALLUCINATION 32 0.0004
573 FOOT FRACTURE 8 0.0004
574 BACTERAEMIA 5 0.0004
575 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
576 ACCIDENT 5 0.0004
577 RASH ERYTHEMATOUS 20 0.0004
578 CONDITION AGGRAVATED 127 0.0004
579 PANCREATITIS 22 0.0004
580 PARAESTHESIA ORAL 6 0.0004
581 VISUAL FIELD DEFECT 3 0.0004
582 GUILLAIN-BARRE SYNDROME 2 0.0004
583 EAR INFECTION 11 0.0004
584 GASTROINTESTINAL DISORDER 37 0.0004
585 FAECES SOFT 3 0.0004
586 EAR PAIN 8 0.0004
587 MOUTH HAEMORRHAGE 3 0.0004
588 RASH PRURITIC 22 0.0004
589 FOOT OPERATION 2 0.0004
590 ORTHOSTATIC HYPOTENSION 7 0.0004
591 HYPERNATRAEMIA 2 0.0004
592 PALPITATIONS 47 0.0004
593 HAEMORRHAGE INTRACRANIAL 6 0.0004
594 FLUID INTAKE REDUCED 2 0.0004
595 BRAIN INJURY 4 0.0004
596 EYE DISORDER 13 0.0004
597 INSURANCE ISSUE 6 0.0004
598 BOWEL MOVEMENT IRREGULARITY 3 0.0004
599 DISSOCIATION 3 0.0004
600 URINARY RETENTION 13 0.0004
601 PERICARDIAL EFFUSION 9 0.0004
602 CEREBRAL ISCHAEMIA 2 0.0004
603 ATRIOVENTRICULAR BLOCK 3 0.0004
604 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
605 APHTHOUS ULCER 3 0.0004
606 EXPOSURE DURING PREGNANCY 24 0.0004
607 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
608 FAILURE TO THRIVE 2 0.0004
609 EYE DISCHARGE 4 0.0004
610 TREATMENT NONCOMPLIANCE 21 0.0004
611 PETECHIAE 4 0.0004
612 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
613 FOOD CRAVING 2 0.0004
614 ORAL CANDIDIASIS 5 0.0004
615 BLOOD LACTIC ACID INCREASED 2 0.0004
616 DRUG SCREEN POSITIVE 3 0.0004
617 NASAL DISCOMFORT 3 0.0004
618 JOINT DISLOCATION 4 0.0004
619 SENSORY DISTURBANCE 6 0.0004
620 MUSCLE DISORDER 3 0.0004
621 INJURY 26 0.0004
622 DRY MOUTH 30 0.0004
623 CHEILITIS 2 0.0004
624 PHARYNGITIS STREPTOCOCCAL 4 0.0004
625 MENSTRUATION DELAYED 4 0.0004
626 SWELLING FACE 24 0.0004
627 OESOPHAGITIS 4 0.0004
628 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
629 PHOTOSENSITIVITY REACTION 6 0.0004
630 MUSCLE INJURY 3 0.0004
631 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
632 FEELING COLD 10 0.0004
633 URINARY TRACT INFECTION 61 0.0004
634 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
635 HEART RATE INCREASED 35 0.0004
636 HEPATIC ENZYME INCREASED 24 0.0004
637 HYPOPHAGIA 9 0.0004
638 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
639 HYPERTONIA 2 0.0003
640 PRODUCT USE IN UNAPPROVED INDICATION 86 0.0003
641 HYPERVENTILATION 2 0.0003
642 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0003
643 AMENORRHOEA 6 0.0003
644 NIGHT SWEATS 11 0.0003
645 SPINAL PAIN 4 0.0003
646 HYPERCHLORHYDRIA 2 0.0003
647 SYNCOPE 34 0.0003
648 ENERGY INCREASED 2 0.0003
649 COVID-19 PNEUMONIA 4 0.0003
650 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
651 BLOOD IRON DECREASED 4 0.0003
652 GASTROINTESTINAL INFECTION 3 0.0003
653 RESPIRATORY DISORDER 10 0.0003
654 ABDOMINAL DISCOMFORT 56 0.0003
655 OROPHARYNGEAL DISCOMFORT 3 0.0003
656 HYPOAESTHESIA ORAL 5 0.0003
657 NASOPHARYNGITIS 61 0.0003
658 LIP SWELLING 11 0.0003
659 DERMATITIS ACNEIFORM 2 0.0003
660 WEIGHT INCREASED 73 0.0003
661 LARYNGEAL OEDEMA 2 0.0003
662 MEDICATION ERROR 18 0.0003
663 NAUSEA 253 0.0003
664 SPINAL DISORDER 3 0.0003
665 PREMATURE DELIVERY 5 0.0003
666 ORAL PAIN 7 0.0003
667 RASH PAPULAR 7 0.0003
668 LOWER LIMB FRACTURE 6 0.0003
669 ABDOMINAL PAIN UPPER 64 0.0003
670 ERUCTATION 6 0.0003
671 MALAISE 136 0.0003
672 FEELING HOT 19 0.0003
673 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
674 CARDIAC FLUTTER 2 0.0003
675 DYSTONIA 6 0.0003
676 BLOOD POTASSIUM INCREASED 5 0.0003
677 COVID-19 54 0.0003
678 PHARYNGEAL SWELLING 3 0.0003
679 TINNITUS 14 0.0003
680 OXYGEN SATURATION DECREASED 17 0.0003
681 BLADDER DISORDER 3 0.0003
682 HYPOAESTHESIA 45 0.0003
683 OVARIAN CYST 3 0.0003
684 SALIVARY HYPERSECRETION 3 0.0003
685 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
686 PERICARDITIS 5 0.0003
687 SINUS CONGESTION 4 0.0003
688 DISCOMFORT 18 0.0003
689 PULMONARY EMBOLISM 28 0.0003
690 EAR DISCOMFORT 3 0.0003
691 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
692 RESPIRATORY ARREST 8 0.0003
693 DRUG INEFFECTIVE 380 0.0003
694 HYPERTRANSAMINASAEMIA 2 0.0003
695 FORMICATION 2 0.0003
696 EXTRASYSTOLES 2 0.0003
697 COLD SWEAT 5 0.0003
698 FLATULENCE 16 0.0003
699 MOVEMENT DISORDER 9 0.0003
700 MAJOR DEPRESSION 2 0.0003
701 DYSPHONIA 16 0.0003
702 NASAL CONGESTION 16 0.0003
703 TOOTH FRACTURE 3 0.0003
704 EXTRA DOSE ADMINISTERED 11 0.0003
705 BLINDNESS TRANSIENT 2 0.0003
706 OROPHARYNGEAL PAIN 25 0.0003
707 SKIN HAEMORRHAGE 4 0.0003
708 THROMBOCYTOPENIA 30 0.0003
709 PARAESTHESIA 42 0.0003
710 CARDIAC ARREST 22 0.0003
711 PNEUMONIA 86 0.0003
712 UNEVALUABLE EVENT 20 0.0003
713 DERMATITIS CONTACT 3 0.0003
714 CHOLECYSTECTOMY 3 0.0003
715 FEELING JITTERY 5 0.0003
716 HYPERTHERMIA 2 0.0003
717 MYOCARDITIS 3 0.0003
718 ACUTE RESPIRATORY FAILURE 5 0.0003
719 RASH MACULAR 9 0.0003
720 HAEMORRHAGIC STROKE 2 0.0003
721 CYANOSIS 4 0.0003
722 SINUS DISORDER 5 0.0003
723 INFLUENZA 28 0.0003
724 LIVER DISORDER 11 0.0002
725 HYPERSENSITIVITY 46 0.0002
726 PRESYNCOPE 6 0.0002
727 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
728 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
729 LIVER INJURY 6 0.0002
730 ILEUS 3 0.0002
731 TOOTH EXTRACTION 3 0.0002
732 HEMIPLEGIA 2 0.0002
733 DEHYDRATION 32 0.0002
734 CARDIO-RESPIRATORY ARREST 10 0.0002
735 DERMATITIS ALLERGIC 3 0.0002
736 MUSCLE ATROPHY 3 0.0002
737 CIRCULATORY COLLAPSE 4 0.0002
738 ALOPECIA 46 0.0002
739 PANCYTOPENIA 13 0.0002
740 HYSTERECTOMY 2 0.0002
741 PRURITUS 88 0.0002
742 NEUROTOXICITY 4 0.0002
743 HYPERKALAEMIA 8 0.0002
744 GASTRITIS 6 0.0002
745 HEART RATE DECREASED 8 0.0002
746 IMMUNE SYSTEM DISORDER 3 0.0002
747 TOOTH INFECTION 3 0.0002
748 DYSMENORRHOEA 3 0.0002
749 FEMUR FRACTURE 7 0.0002
750 DRUG ERUPTION 4 0.0002
751 MYALGIA 38 0.0002
752 SNEEZING 5 0.0002
753 MOBILITY DECREASED 16 0.0002
754 HEAVY MENSTRUAL BLEEDING 2 0.0002
755 LEUKOCYTOSIS 4 0.0002
756 LUPUS-LIKE SYNDROME 2 0.0002
757 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
758 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
759 HYPERHIDROSIS 28 0.0002
760 HEPATIC ENCEPHALOPATHY 2 0.0002
761 BLISTER 12 0.0002
762 SKIN REACTION 3 0.0002
763 CEREBROVASCULAR ACCIDENT 36 0.0002
764 FRACTURE 4 0.0002
765 VIRAL INFECTION 7 0.0002
766 PARALYSIS 3 0.0002
767 PRODUCTIVE COUGH 10 0.0002
768 AFFECT LABILITY 2 0.0002
769 ATELECTASIS 2 0.0002
770 INTENTIONAL PRODUCT MISUSE 18 0.0002
771 MUSCULOSKELETAL STIFFNESS 18 0.0002
772 AUTOIMMUNE DISORDER 2 0.0002
773 CHEST DISCOMFORT 21 0.0002
774 HEPATOMEGALY 2 0.0002
775 DISABILITY 4 0.0002
776 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
777 COLON CANCER 3 0.0002
778 HAEMORRHAGE 21 0.0002
779 LEUKOPENIA 10 0.0002
780 DIARRHOEA 129 0.0002
781 HYPOXIA 7 0.0002
782 PRODUCT ADMINISTRATION ERROR 4 0.0002
783 HYPOTHERMIA 2 0.0002
784 SKIN DISCOLOURATION 9 0.0002
785 THYROID DISORDER 3 0.0002
786 NERVOUS SYSTEM DISORDER 6 0.0002
787 ECZEMA 10 0.0002
788 COUGH 53 0.0002
789 CHEST PAIN 35 0.0002
790 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
791 ABSCESS 3 0.0002
792 METABOLIC ACIDOSIS 6 0.0002
793 BREAST PAIN 2 0.0002
794 IRRITABLE BOWEL SYNDROME 4 0.0002
795 PYREXIA 64 0.0002
796 BLOOD GLUCOSE FLUCTUATION 2 0.0002
797 GASTROINTESTINAL PAIN 2 0.0002
798 RESPIRATORY DISTRESS 5 0.0002
799 BLOOD PRESSURE DECREASED 12 0.0002
800 DRY EYE 9 0.0002
801 COMPLETED SUICIDE 15 0.0002
802 RASH MACULO-PAPULAR 4 0.0002
803 WOUND 5 0.0002
804 MUSCULOSKELETAL DISCOMFORT 3 0.0002
805 HERPES ZOSTER 10 0.0002
806 GASTRIC HAEMORRHAGE 2 0.0002
807 DELIRIUM 6 0.0002
808 CAESAREAN SECTION 2 0.0002
809 BLOOD CHOLESTEROL INCREASED 8 0.0002
810 NO ADVERSE EVENT 31 0.0002
811 CARDIAC DISORDER 16 0.0002
812 OSTEOPOROSIS 7 0.0002
813 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
814 CEREBRAL HAEMORRHAGE 6 0.0002
815 BLOOD PRESSURE FLUCTUATION 4 0.0002
816 MYELOSUPPRESSION 6 0.0002
817 TOOTHACHE 3 0.0002
818 LACRIMATION INCREASED 5 0.0002
819 RESTLESS LEGS SYNDROME 3 0.0002
820 BACK PAIN 38 0.0002
821 HYPOACUSIS 7 0.0002
822 THROMBOSIS 13 0.0002
823 EYE SWELLING 6 0.0002
824 URTICARIA 27 0.0002
825 CYST 2 0.0002
826 EPISTAXIS 12 0.0002
827 PHOTOPHOBIA 3 0.0002
828 ACNE 12 0.0002
829 ANGIOEDEMA 7 0.0002
830 HAEMATEMESIS 4 0.0002
831 CYSTITIS 5 0.0002
832 HEPATIC CYTOLYSIS 2 0.0002
833 THERAPY NON-RESPONDER 7 0.0002
834 HAEMATOMA 4 0.0002
835 HAEMORRHOIDS 3 0.0002
836 DYSPEPSIA 15 0.0002
837 DYSPNOEA 86 0.0002
838 PREGNANCY 3 0.0001
839 MENSTRUATION IRREGULAR 4 0.0001
840 NEUTROPENIA 20 0.0001
841 PALLOR 4 0.0001
842 ACUTE HEPATIC FAILURE 2 0.0001
843 TOOTH LOSS 3 0.0001
844 HYPOTENSION 29 0.0001
845 DIVERTICULITIS 4 0.0001
846 ACUTE KIDNEY INJURY 22 0.0001
847 HYPOMAGNESAEMIA 2 0.0001
848 MASS 2 0.0001
849 BURNING SENSATION 10 0.0001
850 KNEE ARTHROPLASTY 3 0.0001
851 MOUTH ULCERATION 3 0.0001
852 MUSCLE SPASMS 26 0.0001
853 LYMPHOPENIA 2 0.0001
854 DEEP VEIN THROMBOSIS 9 0.0001
855 INFECTION 20 0.0001
856 LIVER FUNCTION TEST ABNORMAL 4 0.0001
857 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
858 BONE PAIN 8 0.0001
859 CHILLS 16 0.0001
860 ANAEMIA 26 0.0001
861 DYSURIA 5 0.0001
862 ACUTE MYOCARDIAL INFARCTION 4 0.0001
863 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
864 TACHYCARDIA 12 0.0001
865 RENAL INJURY 4 0.0001
866 IMMUNODEFICIENCY 2 0.0001
867 BLOOD POTASSIUM DECREASED 4 0.0001
868 HOT FLUSH 10 0.0001
869 PAIN IN EXTREMITY 39 0.0001
870 STOMATITIS 8 0.0001
871 EJECTION FRACTION DECREASED 2 0.0001
872 ARRHYTHMIA 6 0.0001
873 EYE PAIN 7 0.0001
874 NEURALGIA 3 0.0001
875 BACK DISORDER 2 0.0001
876 TREATMENT FAILURE 10 0.0001
877 PAIN 74 0.0001
878 AGEUSIA 3 0.0001
879 FUNGAL INFECTION 4 0.0001
880 ABDOMINAL PAIN LOWER 3 0.0001
881 CANDIDA INFECTION 2 0.0001
882 PRODUCT COMPLAINT 3 0.0001
883 PERIPHERAL SWELLING 18 0.0001
884 ERYTHEMA 24 0.0001
885 EMOTIONAL DISTRESS 14 0.0001
886 RESPIRATORY TRACT INFECTION 3 0.0001
887 ABDOMINAL DISTENSION 12 0.0001
888 DEATH 97 0.0001
889 GALLBLADDER DISORDER 2 0.0001
890 BLOOD PRESSURE INCREASED 17 0.0001
891 RESPIRATORY FAILURE 8 0.0001
892 SKIN IRRITATION 5 0.0001
893 HYPOKALAEMIA 5 0.0001
894 RHINORRHOEA 7 0.0001
895 BRONCHITIS 8 0.0001
896 SWELLING 10 0.0001
897 HEPATIC CIRRHOSIS 2 0.0001
898 TARDIVE DYSKINESIA 3 0.0001
899 PAIN IN JAW 3 0.0001
900 HYPOCALCAEMIA 2 0.0001
901 OCULAR HYPERAEMIA 5 0.0001
902 BLOOD URINE PRESENT 2 0.0001
903 GASTRIC ULCER 2 0.0001
904 NEOPLASM MALIGNANT 7 0.0001
905 HYPERTENSION 22 0.0001
906 GLAUCOMA 2 0.0001
907 HERNIA 2 0.0001
908 ABDOMINAL PAIN 24 0.0001
909 ATRIAL FIBRILLATION 10 0.0001
910 LABORATORY TEST ABNORMAL 3 0.0001
911 BLOOD PRESSURE ABNORMAL 2 0.0001
912 POLLAKIURIA 4 0.0001
913 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
914 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
915 FAECES DISCOLOURED 2 0.0001
916 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
917 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
918 CHOLELITHIASIS 3 0.0001
919 ARTHRALGIA 38 0.0001
920 JOINT SWELLING 11 0.0001
921 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
922 THROAT IRRITATION 4 0.0001
923 HAEMATURIA 3 0.0001
924 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
925 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
926 CATARACT 5 0.0001
927 BLOOD GLUCOSE DECREASED 4 0.0001
928 LOCALISED INFECTION 2 0.0001
929 LUNG DISORDER 4 0.0001
930 MYOCARDIAL INFARCTION 14 0.0001
931 COLITIS 3 0.0001
932 FLUID RETENTION 4 0.0001
933 INFLAMMATION 4 0.0001
934 DEAFNESS 2 0.0001
935 JOINT STIFFNESS 2 0.0001
936 FREQUENT BOWEL MOVEMENTS 2 0.0001
937 OEDEMA PERIPHERAL 9 0.0001
938 BLINDNESS 3 0.0001
939 NEUTROPHIL COUNT DECREASED 3 0.0001
940 LUNG NEOPLASM MALIGNANT 3 0.0001
941 ANAPHYLACTIC REACTION 4 0.0001
942 RHABDOMYOLYSIS 3 0.0001
943 SEPSIS 8 0.0001
944 HAEMOPTYSIS 2 0.0001
945 NECK PAIN 4 0.0001
946 RECTAL HAEMORRHAGE 3 0.0001
947 SKIN BURNING SENSATION 5 0.0001
948 EYE IRRITATION 4 0.0001
949 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
950 VAGINAL HAEMORRHAGE 3 0.0001
951 SINUSITIS 7 0.0001
952 RENAL FAILURE 9 0.0001
953 PULMONARY OEDEMA 3 0.0001
954 HEPATIC FAILURE 2 0.0001
955 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
956 PLEURAL EFFUSION 4 0.0001
957 PLATELET COUNT DECREASED 7 0.0001
958 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
959 RENAL DISORDER 3 0.0001
960 BREAST CANCER 6 0.0001
961 IMPAIRED HEALING 2 0.0001
962 INFLUENZA LIKE ILLNESS 5 0.0001
963 CELLULITIS 3 0.0001
964 EYE PRURITUS 2 0.0001
965 RENAL IMPAIRMENT 5 0.0001
966 GASTRIC DISORDER 2 0.0001
967 MUSCULOSKELETAL PAIN 3 0.0001
968 HAEMATOCHEZIA 3 0.0001
969 DYSPNOEA EXERTIONAL 2 0.0001
970 INTESTINAL OBSTRUCTION 2 0.0001
971 DIABETES MELLITUS 4 0.0001
972 CARDIAC FAILURE 4 0.0000
973 DEVICE BREAKAGE 2 0.0000
974 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
975 SKIN EXFOLIATION 4 0.0000
976 BLOOD CREATININE INCREASED 3 0.0000
977 PRODUCT STORAGE ERROR 4 0.0000
978 DRUG WITHDRAWAL SYNDROME 4 0.0000
979 INFUSION RELATED REACTION 3 0.0000
980 DRY SKIN 6 0.0000
981 NEUROPATHY PERIPHERAL 4 0.0000
982 DISEASE RECURRENCE 2 0.0000
983 ARTHRITIS 3 0.0000
984 DRUG ABUSE 3 0.0000
985 FLUSHING 3 0.0000
986 DYSGEUSIA 2 0.0000
987 CARDIAC FAILURE CONGESTIVE 2 0.0000
988 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
989 BLOOD GLUCOSE INCREASED 4 0.0000
990 DRUG DEPENDENCE 3 0.0000
991 ASTHMA 2 0.0000
992 INJECTION SITE PAIN 3 0.0000